Cite
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD -genotype variants and P-uracil concentrations.
MLA
Paulsen, Niels Herluf, et al. “Dihydropyrimidine Dehydrogenase (DPD) Genotype and Phenotype among Danish Cancer Patients: Prevalence and Correlation between DPYD -Genotype Variants and P-Uracil Concentrations.” Acta Oncologica (Stockholm, Sweden), vol. 61, no. 11, Nov. 2022, pp. 1400–05. EBSCOhost, https://doi.org/10.1080/0284186X.2022.2132117.
APA
Paulsen, N. H., Qvortrup, C., Vojdeman, F. J., Plomgaard, P., Andersen, S. E., Ramlov, A., Bertelsen, B., Rossing, M., Nielsen, C. G., Hoffmann-Lücke, E., Greibe, E., Spangsberg Holm, H., Nielsen, H. H., Lolas, I. B. Y., Madsen, J. S., Bergmann, M. L., Mørk, M., Fruekilde, P. B. N., Bøttger, P., … Damkier, P. (2022). Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD -genotype variants and P-uracil concentrations. Acta Oncologica (Stockholm, Sweden), 61(11), 1400–1405. https://doi.org/10.1080/0284186X.2022.2132117
Chicago
Paulsen, Niels Herluf, Camilla Qvortrup, Fie Juhl Vojdeman, Peter Plomgaard, Stig Ejdrup Andersen, Anne Ramlov, Birgitte Bertelsen, et al. 2022. “Dihydropyrimidine Dehydrogenase (DPD) Genotype and Phenotype among Danish Cancer Patients: Prevalence and Correlation between DPYD -Genotype Variants and P-Uracil Concentrations.” Acta Oncologica (Stockholm, Sweden) 61 (11): 1400–1405. doi:10.1080/0284186X.2022.2132117.